SEC Form 3 · accession 0002146210-26-000002
Harmony Biosciences Holdings, Inc. · HRMY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen M. Mollichella
Officer — INT PRINCIAL FINANCIAL OFFICER
Period of report
Jul 16, 2026
Accepted (ET)
Jul 22, 2026 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001802665
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,506 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $37.46 | holding | — | — | — | — | Jul 19, 2031 | Common Stock | 12,172 | — | D |
| Stock OptionF2 | $30.69 | holding | — | — | — | — | Jan 24, 2034 | Common Stock | 8,500 | — | D |
| Stock OptionF3 | $38.01 | holding | — | — | — | — | Jan 25, 2035 | Common Stock | 7,050 | — | D |
| Stock OptionF4 | $36.76 | holding | — | — | — | — | Jan 22, 2036 | Common Stock | 20,750 | — | D |
| Restricted Stock UnitF5 | — | holding | — | — | — | — | — | Common Stock | 2,625 | — | D |
| Restricted Stock UnitF6 | — | holding | — | — | — | — | — | Common Stock | 3,488 | — | D |
| Restricted Stock UnitF7 | — | holding | — | — | — | — | — | Common Stock | 5,900 | — | D |
Explanation of responses
- F1The stock option vests with respect to 50% of the underlying shares on July 13, 2023, with the remaining shares vesting ratably on a monthly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- F2The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- F3The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- F4The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- F5The outstanding restricted stock units shall vest in two equal annual installments beginning on January 24, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- F6The outsanding restricted stock units shall vest in three equal annual installments beginning on January 25, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
- F7The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.